Sphera Funds Management Ltd. Keros Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$41.44 - $59.32 $5.33 Million - $7.63 Million	-128,638 Reduced 81.03%	30,119 $1.29 Million
Q4 2022 Feb 14, 2023	SELL	$39.45 - $51.77 $1.9 Million - $2.49 Million	-48,062 Reduced 23.24%	158,757 $7.62 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $3.86 Million - $5.57 Million	138,822 Added 204.16%	206,819 $7.78 Million
Q2 2022 Aug 15, 2022	SELL	$26.03 - $67.04 $1.86 Million - $4.8 Million	-71,584 Reduced 51.28%	67,997 $1.88 Million
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $838,188 - $1.18 Million	19,900 Added 16.63%	139,581 $7.59 Million

Q4 2021 Feb 14, 2022	BUY	$36.95 - $62.89 $4.42 Million - $7.53 Million	119,681 New	119,681 $7 Million

153

26.7M

47.6K

34.5K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.18B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.